ArticleBMC cancer2022

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies.

Uwe Platzbecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.